Skip to main content
WELLBIOTEC CO.,LTD logo

WELLBIOTEC CO.,LTD — Investor Relations & Filings

Ticker · 010600 ISIN · KR7010600005 KO Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2020-11-10 Major Shareholding Noti…
Country KR South Korea
Listing KO 010600

About WELLBIOTEC CO.,LTD

http://www.wellbiotec.com/?language=eng

WELLBIOTEC CO.,LTD. is a diversified company with operations in several sectors. Its business activities include the development and distribution of biopharmaceutical products, such as specialized medicines, health functional foods, and diagnostic kits. The company is also involved in the electric vehicle (EV) charging business and logistics. Additionally, it manufactures and sells leather products for fashion goods, including shoes and handbags.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically collateral rights) by Sangsangin Plus Savings Bank and its special related parties in Well Biotech Co., Ltd. This document type is specifically designed for reporting significant shareholding changes (crossing thresholds) and is classified as a Major Shareholding Notification.
2020-11-10 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the appointment of a new outside director, including their name, term, and professional background, following an Extraordinary General Meeting. This falls directly under the category of Board/Management Information (MANG) as it pertains to changes in the company's board composition.
2020-11-06 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) for the company 'Well Biotech'. It details the resolutions passed, including the approval of articles of incorporation changes and the appointment of new directors (both executive and outside). This falls directly under the category of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it reports the outcome of shareholder voting at a general meeting.
2020-11-06 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details specific changes to the capital structure, including payment dates, share issuance details, and third-party allocation. In the context of Korean corporate filings (DART), this is a regulatory filing concerning capital changes. Since it specifically details the issuance of new shares and capital structure adjustments, it falls under the 'Share Issue/Capital Change' category.
2020-11-06 Korean
기타안내사항(안내공시)
Share Issue/Capital Change Classification · 100% confidence The document is a short regulatory announcement from Well Biotech regarding the expiration of a lock-up period (protection period) for common shares issued via a third-party capital increase. It does not fit into specific categories like M&A, dividends, or financial reports. As it is a general regulatory disclosure regarding share status and capital structure, it falls under the RNS (Regulatory Filings) category.
2020-11-04 Korean
[기재정정]타법인주식및출자증권처분결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from the Korean DART system regarding the 'Decision to Dispose of Shares and Securities of Other Corporations' (타법인 주식 및 출자증권 처분결정). It details a correction (정정신고) to a previous filing concerning the disposal of shares in Biogenic Korea. Since this is a specific regulatory announcement regarding a corporate transaction (asset disposal) that does not fit into categories like M&A (which usually implies full company takeovers) or share buybacks (which is POS), it falls under the general regulatory filing category.
2020-11-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.